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INTRODUCTION
Depression is one of the leading causes of disability and disease burden. 1 It is associated with the most years lost to disability of all diseases worldwide. Identifying depression in patients with chronic physical health problems is important for several reasons. First, a number of studies suggest depression is approximately two to three times as prevalent in such populations, including patients with cancer, 2 chronic heart disease, 3, 4 and chronic obstructive pulmonary disease (COPD). 5 Secondly, there appears to be greater disease burden, in terms of healthcare use and functional disability, in people with comorbid depression compared with those with physical health problems alone. 6, 7 Thirdly, mortality is greater in several medical conditions when depression is present -heart disease, 8 COPD, 9 stroke, 10 cancer 11 -and in medically ill older adults. 12 Furthermore, morbidity and mortality may diminish with effective treatment of depression. 13, 14 There is convincing evidence that many cases of depression go unrecognised in the general population and in primary care. [15] [16] [17] Reasons for under-recognition include a low rate of mood problems as the presenting All published studies that met the eligibility criteria were assessed for methodological quality using the Scottish Intercollegiate Guidelines Network (SIGN) checklist for diagnostic studies. 29 Data were extracted independently by at least two authors, and 2×2 tables were constructed, from which the primary outcomes were calculated: that is sensitivity, specificity, and likelihood ratios.
To maximise the available data, the most consistently reported and recommended cut-off points were extracted for each of the scales. There are limitations to this approach, as noted by Furukawa and colleagues, 34 ;who found that the optimal cut-offs for the General Health Questionnaire (GHQ)-12 and GHQ-28 differed according to the prevalence of depression, and it is likely there are similar problems for most other scales. However, a Bayesian approach makes allowance for variations according to prevalence (see below), therefore seeking to take into account this potential limitation.
Data synthesis and analysis
A bivariate diagnostic accuracy meta-analysis was conducted using Stata (version 10) with the metandi 35 commands, to obtain pooled estimates of sensitivity, specificity, and likelihood ratios. This method was originally developed as a mixed effects regression model for meta-analysis of trials, and modified more recently for studies of diagnostic accuracy. 36, 37 Between-study heterogeneity was assessed using the I 2 statistic. 38 In addition, publication bias was assessed by visual inspection of funnel plots, and formal use of Egger's test. 39 A Bayesian curve analysis was also undertaken; this plots post-test conditional probabilities from all possible pre-test probabilities (prevalence). The area under the Bayesian curve (AUC) for positive results can be used as a statistical comparison of rule-in success and 1 -AUC for negatives results used as an indicator of rule-out success. An area of more than 0.75 can be interpreted as 'satisfactory' and more than 0.80 interpreted as 'good'. If a test achieved more than 0.90 in a rule-in capacity, this was considered sufficient for a recommendation that this tool could be used on its own for case finding.
Additional meta-regression analyses were planned to assess differences in diagnostic accuracy for disease groups. Such analyses were conducted on a scale when there were a minimum of four studies for at least two disease groups.
RESULTS
A total of 113 studies on 20 826 participants met the eligibility criteria of the review (see Figure 1 for full details on study flow information). These studies were both on populations specifically targeted for a chronic physical health problem (such as cancer, heart disease, and stroke), and in general medical settings where all were physically ill and a substantial proportion had a chronic physical health problem. In total, 83 studies specifically targeted people with chronic physical health problems in any setting (Appendix 2). The mean prevalence of depression was 0.25 (95% confidence interval CI] = 0.05 to 0.61). A further 30 studies were on people in general medical settings, with a mean prevalence of depression of 0.24 (95% CI = 0.04 to 0.52). Studies recruiting for chronic physical health problem Sensitivity and specificity Table 1 provides an evidence summary for the various scales on people recruited for specific chronic physical health problems. There was moderate to high sensitivity for most scales. The tools with the highest sensitivity were the two stem questions (0.98; 95% CI = 0.85 to 0.99), followed by the GHQ-28, Patient Health Questionnaire (PHQ)-9, Beck Depression Inventory (BDI), and BDI non-somatic (Table 1) . Sensitivity was lowest for the one-item measure. The Zung Self Rating Depression Scale had the highest specificity 0.92 (95% CI = 0.68 to 0.98). This was followed by the two stem questions, the Hamilton Depression Rating Scale (HDRS), PHQ-9 and the Centre for Epidemiologic Studies Depression Scale (CES-D); all had high specificity. The lowest specificity was found for the one-item measure and the GHQ-12.
Rule-in (positive predictive value) and rule-out accuracy (negative predictive value) Using Bayesian plots of conditional probabilities to examine rule-in and rule-out performance, only three tools had less than satisfactory rule-in performance, namely the single question: the Geriatric Depression Scale (GDS-30) and GHQ-12. The optimal single tool was the Zung, although it did not reach the a priori standard for recommendation when applied alone. For rule-out performance, four methods were not satisfactory. These were the single queston, the Hospital Anxiety and Depression Scale (HADS), GDS-30, and GHQ-12. The optimal tools were the two stem questions and GHQ-28. Overall accuracy was best for the two stem questions, Zung, PHQ-9, and GHQ-28. However, it should be noted that data for the Zung scale were based on just four studies and a relatively small total sample size (n = 190).
Meta-regression comparing the diagnostic accuracy for different disease groups was only possible for the BDI and HADS-D. There was no evidence of difference in sensitivity (beta = 0.93, P = 0.34) and specificity (beta = 1.56, P = 0.35) of the HADS between stroke and cancer patients. There was no evidence of difference in sensitivity (beta = 1.49, P = 0.60), but some evidence for differences in specificity (beta = 1.20, P = 0.02) of the BDI between heart disease and cancer patients. Table 2 summarises the results for general medical settings. There were only three scales that provided sufficient data for analyses. All these scales performed equally well in this setting as compared to populations specifically targeted for chronic physical health problems with a large overlap in confidence intervals. Table 2) .
Studies in general medical settings

Rule-in and rule-out accuracy
Using the same methodology for each measure in general medical settings and correcting for prevalence using a Bayesian analysis, the GDS-15 was most successful and the HADS least successful. No method came close to the a priori; standard for rule-in performance when applied alone. For rule-out accuracy, the HADS was significantly less accurate than the GDS-15 (Area HADS = 0.71, 95% CI = 0.68 to 0.74 versus Area GDS-15 = 0.78, 95% CI = 0.75 to 0.82).
DISCUSSION
Most of the scales performed adequately as case-identification measures for depression, with modest differences in validity coefficients. Most studies targeted chronic physically ill populations rather than general medical settings such as primary care. In order to detect depression in those with chronic physically ill health, the most sensitive instruments appear to be two stem questions, PHQ-9, and GHQ-28. The most specific measure was the Zung. Overall, optimal accuracy was achieved by the two stem questions, Zung, PHQ-9, and GHQ-28. However, it should be noted that estimates on the Zung and GHQ-28 analysis were based on a relatively small sample size; therefore, it is possible that conclusions regarding these scales may change with further data. No method came close to the a priori standard for case-finding recommendation when applied alone.
Another important factor to consider when comparing the different measures is the ease of implementation. The Zung is a 20-item scale and therefore is more resource intensive and less likely to be implemented in primary care compared to shorter measures. Taking into account both the psychometric properties and ease of implementation, it would appear the two stem questions may be the preferred measure for case identification in patients with chronic physical health problems. From these data, the authors do not recommend relying upon a single question alone, and recommend two questions as a minimum initial enquiry. This is consistent with previous pooled data in primary care40 and cancer settings. 41 In general medical settings, there were fewer studies, and analysable data were only available for the GDS, GDS-15, and HADS-D. Specificity was similar for all three scales but sensitivity was highest in the GDS-15.
Further research is needed to confirm whether the optimal tools in the chronically ill (two stem questions, PHQ-9, and the Zung) perform equally well in general medical samples.
There are several limitations to the results of this systematic review. First, there was moderate to high heterogeneity for most measures. Secondly, there is a paucity of validity studies using the ICD-10 as the criterion standard compared with the DSM-IV, which may favour tools using DSM items, and therefore the authors recommend future examination using this outcome. Thirdly, there were widely used or potentially useful scales that had few or no studies in the physically ill; these include the Montgomery-Asberg Depression Scale (MADRS), 42 and the Clinically Useful Outcome Depression Scale (CUDOS). 43 Further research is needed on these scales for people with chronic physical health problems. Fourthly, there were a number of different semistructured methods used to determine the interview-based diagnosis, including the Schedules for Clinical Assessment in Neuropsychiatry (SCAN), 44 the Composite International Diagnostic Interview (CIDI), 45 the Structured and Clinical Interview for DSM-III-R (SCID), 46 and the Diagnostic Interview schedule (DIS), 47 all of which may vary in diagnostic accuracy. A further limitation is the lack of cost-effectiveness analyses assessing the cost impact of false positives associated with the use of case-identification measures. However, it should be noted that the cost-effectiveness of case identification is very complex to model and requires a number of assumptions concerning probabilities assigned to events in the depression treatment care pathway, and explicit values of treatment outcomes. 48 Therefore, such issues were considered beyond the scope of this paper.
It should also be acknowledged that the use of case-identification tools may not be translated into real benefit in clinical practice. Case identification may bring limited benefit if there are no effective assessment and treatment services in place, as professionals may be reluctant to make a diagnosis of depression if they have limited resources on which to call. 49 The aim of the NICE guideline for which this review was conducted, 31 is to promote the commissioning of such services. The impact of case finding on the individual consultation may be important, since the use of the PHQ-9 severity questionnaire can cause a tension within the consultation, with GPs struggling to manage formal assessment versus personal enquiry. 50 From this data synthesis, it appears that there are a number of instruments for the case identification of depression in the medically ill that have similar accuracy. A consideration of both accuracy and acceptability suggests that the two stem questions may be the most efficient initial method, although further validation is needed. We do not recommend the use of a single question used alone. GPs and practice nurses should not rely on the case-finding questions alone; they should be confident to complete an assessment of the patient's mental state and risk, and a pathway within the practice should be in place (particularly when it is the practice nurse who has done the case finding). Resources within the practice should be available to support patients who have depression and a chronic physical health problem, and primary care practitioners should have well-defined links with local primary care mental health services, which should offer appropriate interventions for such patients, including a collaborative care approach as recommended by NICE.  PHQ-953  PHQ-254 3. Two stem questions: 55  These are similar to the PHQ-2 except that the scoring system is dichotomous ('yes' or 'no') rather than the Likert scale used for both PHQ-9 and PHQ-2, and the period of reported low mood or loss of interest is 1 month rather than 2 weeks 4. General Health Questionnaire: 56  GHQ-12  GHQ-28 5. Centre of Epidemiological Studies -Depression (CES-D) 57 
Geriatric Depression Scale (GDS)
 GDS-30 58  GDS-15 59 7. Zung Self Rating Depression Scale 60 8. Hospital Anxiety and Depression Scale -Depression 61 9. Hamilton Depression Rating Scale HDRS 62  Both 17-and 21-item versions 10. Montgomery-Asberg Depression Rating Scale (MADRS) 63 11. Clinically Useful Depression Outcome Scale 64 
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